Physician profile
Badih A Adada
NPI 1225128705
$1,310.41
in general payments reported to CMS, 2019-2025
18 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $89.34 · 2021: $82.79 · 2022: $191 · 2023: $74.78 · 2024: $461 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $488.27 | 2019-2024 | Na |
| Stryker Corporation | $172.32 | 2024 | Adherus Autospray Dural Sealant |
| Karl Storz Endoscopy-America | $142.43 | 2019 | |
| Abbott Laboratories | $75.50 | 2023-2024 | Infinity |
| Boston Scientific Corporation | $73.44 | 2021-2025 | Watchman Flx |
| Carbofix Spine INC | $52.87 | 2024 | |
| Medtronic, INC. | $43.66 | 2025 | Percept PC Brainsense |
| Medtronic USA, INC. | $39.70 | 2019 | |
| Microtransponder, INC. | $36.89 | 2024 | |
| Integra Lifesciences Corporation | $32.58 | 2019 | |
| Revance Therapeutics, INC. | $29.20 | 2024 | Daxxify |
| Takeda Pharmaceuticals U.S.A., INC. | $23.03 | 2023 | |
| Acadia Pharmaceuticals INC | $20.05 | 2022 | |
| Cook Medical LLC | $18.27 | 2025 | Zilver Ptx |
| Baxter Healthcare | $16.39 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.91 | 2025 | |
| Bioventus LLC | $15.81 | 2025 | Nexus-10 Mkii |
| Teva Pharmaceuticals USA, INC. | $14.09 | 2024 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Badih Adada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.